Researchers developed an AI model using multimodal data to accurately diagnose different types of dementia, enhancing early and personalized treatment.
Iovance looks to advance its non-small cell lung cancer therapy – Pharmaceutical Technology
Lifileucel received a biologics license application (BLA) in May 2023, with a Prescription Drug User Fee Act (PDUFA) target action date set for 25 November